XCANCER CONSULTING Trademark

Trademark Overview


On Monday, December 1, 2025, a trademark application was filed for XCANCER CONSULTING with the United States Patent and Trademark Office. The USPTO has given the XCANCER CONSULTING trademark a serial number of 99523477. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, April 14, 2026. This trademark is owned by Urology Cancer Center, P.C.. The XCANCER CONSULTING trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Consulting services in the field of medical care, oncology, and theranostics.
xcancer consulting

General Information


Serial Number99523477
Word MarkXCANCER CONSULTING
Filing DateMonday, December 1, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, April 14, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkX CANCER CONSULTING
Goods and ServicesConsulting services in the field of medical care, oncology, and theranostics.

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 1, 2025
Primary Code044
First Use Anywhere DateMonday, July 18, 2022
First Use In Commerce DateMonday, July 18, 2022

Trademark Owner History


Party NameUrology Cancer Center, P.C.
Party Type10 - Original Applicant
Legal Entity Type57 - NOT AVAILABLE
AddressOmaha, NE 68130
US

Trademark Events


Event DateEvent Description
Monday, December 1, 2025NEW APPLICATION ENTERED
Monday, December 1, 2025APPLICATION FILING RECEIPT MAILED
Thursday, February 12, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 3, 2026ASSIGNED TO EXAMINER
Tuesday, April 14, 2026NON-FINAL ACTION WRITTEN
Tuesday, April 14, 2026NON-FINAL ACTION E-MAILED
Tuesday, April 14, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED